Anti-Sagging Paradigm Shifts Medical Aesthetics Market in South Korea

SEOUL, South Korea, March 17, 2026 – The global medical aesthetics market is undergoing a significant transformation, moving beyond traditional approaches focused on superficial signs of aging towards a deeper, structural understanding of skin laxity. This shift, termed the “Anti-Sagging” paradigm, prioritizes addressing the root causes of aging – the decline of collagen in the dermal layer and the weakening of the skin’s support structures.

From Fillers to Biostimulators: A Market Evolution

Historically, aesthetic procedures have largely centered on temporary solutions like Hyaluronic Acid (HA) fillers and toxins to reduce wrinkles and restore volume. However, the Anti-Sagging trend is driving demand for biostimulators, substances that stimulate neocollagenesis – the creation of new collagen. Polycaprolactone (PCL), a biodegradable polymer, is gaining prominence for its ability to rebuild the skin’s foundational structure.

DEXLEVO’s GOURI: A Liquid PCL Collagen Stimulator

Amidst this evolving landscape, DEXLEVO’s liquid PCL collagen stimulator, ‘GOURI,’ is attracting considerable attention. Developed using the proprietary CESABP (Collagenesis-Enabled Solubilized Active and Biodegradable Polymer) technology, GOURI distinguishes itself by being entirely free of microparticles.

The Advantage of Uniform Collagen Regeneration

GOURI’s fully liquid formulation allows for superior spreadability, naturally dispersing throughout the entire dermal layer upon injection. This promotes uniform collagen regeneration and improved elasticity across the entire face, unlike conventional particle-based fillers that act locally at the injection site. This comprehensive approach aims to enhance overall skin quality.

Clinical Data Presented at IMCAS World Congress 2026

At the IMCAS World Congress 2026 in Paris, Dr. Seung-min Oh presented clinical data on GOURI, highlighting a “triple effect”: redness reduction, skin texture improvement and volume formation. He likewise detailed precision injection strategies based on facial anatomy. Medisobija News reported on Dr. Oh’s presentation, emphasizing the precision medical value of liquid PCL.

“Thanks to the unique spreadability of the fully liquid type PCL, GOURI can induce natural collagen regeneration across the entire face,” stated Dr. Seung-min Oh, Chief Director of O& Clinic and Academic Chair of the Korean Association of Laser, Dermatology, and Trichology. “By precisely leveraging this spreadability with a deep understanding of anatomical structures, we can provide patients with the most natural and healthy results. It is time for ‘Precision Aesthetics,’ rooted in clinical data, to develop into the universal standard.”

About DEXLEVO

DEXLEVO is an innovator in the medical aesthetic device industry and the developer of GOURI, the world’s first fully liquid type PCL-based collagen stimulator. The company continues to build the clinical and academic foundation for Anti-Sagging solutions globally. Learn more at DEXLEVO’s website.

References:

• IMCAS World Congress 2026. GOURI Symposium. Presented at: IMCAS World Congress 2026; January 31, 2026; Paris, France.
• Medisobija News. Dr. Seung-min Oh proves precision medical value of liquid PCL GOURI at IMCAS Paris 2026. Published February 5, 2026. Accessed March 13, 2026. https://www.medisobizanews.com/news/articleView.html?idxno=134310